
Erin Ann Bohula MD
Adult Congenital Heart Disease
Cardiologist, Brigham and Women's Hospital; Investigator, TIMI Study Group
Join to view full profile
75 Francis StBoston, MA 02115
Phone+1 617-732-6660
Dr. Bohula is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2010 - 2013
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2007 - 2010
Harvard Medical SchoolClass of 2007
Certifications & Licensure
MA State Medical License 2009 - 2027
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Critical Care Medicine
Clinical Trials
- IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103) Start of enrollment: 2005 Oct 17
- Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events Start of enrollment: 2013 Apr 25
Publications & Presentations
PubMed
- Acute Kidney Injury and Outcomes in the Cardiac Intensive Care Unit: Insights from the Critical Care Cardiology Trials Network.Narayana Sarma V Singam, Mitchell Padkins, Alexander I Papolos, Benjamin B Kenigsberg, David Berg
Journal of Intensive Care Medicine. 2026-12-01 - DPP3 as a Biomarker in Patients with Cardiovascular Critical Illness.Gurleen Kaur, Andre M Small, Andrea Bellavia, Jacob A Burns, Nicholas Chiu
Journal of Cardiac Failure. 2026-10-27 - Variation in Vasoactive Treatment Selection for Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network (CCCTN).David E Hamilton, Jackson L Shriver, Siddharth M Patel, Jeong-Gun Park, Zoe E Michos
Circulation. Heart Failure. 2026-09-01
Journal Articles
- Cardiovascular Safety of Lorcaserin in Overweight or Obese PatientsErin A Bohula, Stephen D Wiviott, Benjamin M Scirica, Darren K McGuire, Marc S Sabatine, Marc P Bonaca, Christian T Ruff, Silvio E Inzucchi, The New England Journal of Medicine
- Cardiovascular Safety of Lorcaserin in Overweight or Obese PatientsChristina L. Fanola, Darren K. McGuire, Silvio E. Inzucchi, Erin A. Bohula, The New England Journal of Medicine
Press Mentions
Time to Overcome PCSK9i Inertia: New Data, Future OptionsNovember 24th, 2025
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke - VESALIUS-CVNovember 21st, 2025
Evolocumab Reduces Cardiac Events in High-Risk Patients Without Prior MI or Stroke: NEJMNovember 19th, 2025
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: